← Back to Clinical Trials
Recruiting NCT07413406

NCT07413406 Comparing Structured Retrieval Practice and Reading-Based Education for Dementia Caregivers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07413406
Status Recruiting
Phase
Sponsor Virginia Wesleyan University
Condition Dementia
Study Type INTERVENTIONAL
Enrollment 65 participants
Start Date 2025-10-03
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Structured Retrieval PracticeReading-Based Education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 65 participants in total. It began in 2025-10-03 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Caring for a person living with dementia can be stressful, and many family caregivers report limited access to effective educational resources for managing dementia-related behaviors and caregiver stress. This study will evaluate a learning-based educational intervention called structured retrieval practice (SRP), which is designed to improve long-term learning by encouraging repeated recall of information with feedback. Informal dementia caregivers will be randomly assigned to learn caregiving and self-care strategies using either SRP or a traditional reading-based educational approach. Participants will be assessed on their knowledge, confidence in caregiving skills, stress levels, and perceptions of dementia-related behavioral symptoms over multiple follow-up periods. The study will also examine whether the SRP intervention is feasible and acceptable for caregivers in real-world settings.

Eligibility Criteria

Inclusion Criteria: * Adults aged 50 years or older * Informal (unpaid) caregiver for a family member or friend living with dementia * Providing ongoing assistance or support to the individual with dementia * Reports moderate to high perceived stress, defined as a score of 14 or higher on the Perceived Stress Scale (PSS-10) * Able to speak and read English * Able to complete study procedures either in person or remotely * Has access to a computer, tablet, or smartphone with internet access * Willing and able to provide informed consent Exclusion Criteria: * Paid or professional caregivers (e.g., home health aides) * Caregivers younger than 50 years of age * Caregivers reporting low perceived stress (PSS-10 score below 14) * Caregivers providing assistance to an individual without evidence of cognitive - impairment, as determined by a dementia screening interview (AD8 score \< 2) * Inability to complete study procedures due to cognitive, sensory, or technological limitations * Failure to meet study screening requirements or provide informed consent

Contact & Investigator

Central Contact

Robert Ariel, PhD

✉ confidentcarestudy@gmail.com

📞 757-455-3368

Frequently Asked Questions

Who can join the NCT07413406 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, studying Dementia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07413406 currently recruiting?

Yes, NCT07413406 is actively recruiting participants. Contact the research team at confidentcarestudy@gmail.com for enrollment information.

Where is the NCT07413406 trial being conducted?

This trial is being conducted at Virginia Beach, United States.

Who is sponsoring the NCT07413406 clinical trial?

NCT07413406 is sponsored by Virginia Wesleyan University. The trial plans to enroll 65 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology